Understanding Longevity Escape Velocity and Its Implications

Our guest in this episode is Karl Pfleger. Karl is an angel investor in rejuvenation biotech startups, and is also known for creating and maintaining the website Aging Biotech Info. That website describes itself as “Structured info about aging and longevity”, and has the declared mission statement, “Everything important in the field (outside of academia), organized.”

Previously, Karl worked at Google from 2002 to 2013, as a research scientist and data analyst, applying AI and machine learning at scale. He has a BSE in Computer Science from Princeton, and a PhD in Computer Science and AI from Stanford.

Previous London Futurists Podcast episodes mentioned in this conversation:

• Ep 74: The Longevity Singularity, with Daniel Ives
• Ep 45: Generative AI drug discovery breakthrough, with Alex Zhavoronkov
• Ep 12: Pioneering AI drug development, with Alex Zhavoronkov

Other selected follow-ups:

• AgingBiotech.Info
• Lifespan.io rejuvenation roadmap
• AgingDB list
• Stealth Biotherapeutics
• NewLimit
• Juvenity
• Juvena Therapeutics
• Immunis
• Partnership between Calico and AbbVie
• Hevolution
• Unity Biotechnology
• Here's Why resTORbio Fell Over 83% Today
• A4LI Responds to NIH Reform Proposal
• Great Desire for Extended Life and Health amongst the American Public - a paper by Karl Pfleger. Kristen Fortney, Joe Betts-LaCroix and others, 
• LEV achieved for young people before it is achieved for old people
• Longevity Biotech Fellowship
• Foresight Institute

An Acxiom podcast where we discuss marketing made better, bringing you real...

Listen on: Apple Podcasts   Spotify

Listen on: Apple Podcasts   Spotify